影响地塞米松预防腋路臂丛阻滞后反跳痛效果的因素
该前瞻性研究纳入104例接受腋路臂丛阻滞下行日间上肢手术的患者,术前静脉给予地塞米松0.1 mg kg-1。36例(34.6%)发生反跳痛;术前夜间痛醒、严重焦虑、高灾难化评分及低唾液皮质醇水平与反跳痛风险升高相关,3个月持续疼痛(27%)与术后反跳痛存在关联。
要点
- 术前夜间痛醒、严重焦虑、高灾难化评分及低唾液皮质醇可能降低地塞米松预防反跳痛的效果。
- 地塞米松0.1 mg kg-1静脉给药后反跳痛发生率为34.6%。
- 术后反跳痛与3个月持续疼痛相关。
核心结论
- 术前夜间痛醒、严重焦虑、高灾难化评分及低唾液皮质醇水平是可能降低地塞米松预防反跳痛效果的因素。
研究设计与样本
- 前瞻性研究,纳入104例接受腋路臂丛阻滞下行日间上肢手术的患者,术前静脉给予地塞米松0.1 mg kg-1。
主要发现
- 104例中36例(34.6%)发生反跳痛。
- 术前夜间痛醒(OR=3.09,P=0.03)、严重焦虑(OR=3.54,P=0.01)、高灾难化评分(OR=4.14,P=0.01)及低唾液皮质醇水平(<1147 pg ml-1)(OR=3.33,P=0.02)与反跳痛风险升高相关。
- 3个月持续疼痛发生率为27%,且与术后反跳痛存在关联(P=0.04)。
关键数值与推荐
- 反跳痛定义为术后24小时内数字评定量表>7。
- 低唾液皮质醇水平定义为<1147 pg ml-1。
临床怎么用
- 对术前存在夜间痛醒、严重焦虑、高灾难化评分或低唾液皮质醇的患者,可考虑个性化预防策略以降低反跳痛风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rebound pain after regional anaesthesia remains a significant clinical problem. Intravenous dexamethasone is commonly used as an adjuvant to prevent rebound pain although its effectiveness varies among patients. We aimed to identify phenotypic and biological factors influencing glucocorticoid sensitivity contributing to dexamethasone resistance in the prevention of rebound pain. METHODS: Patients undergoing ambulatory upper limb surgery with an axillary brachial plexus block were enrolled prospectively to receive dexamethasone (0.1 mg kg-1 i.v.) before surgery. Preoperative factors analysed encompassed clinical aspects (central sensitivity, anxiety, and pain scores) and biological parameters (salivary cortisol, annexin-A1, and blood inflammatory markers). Postoperative outcomes comprised rebound pain incidence (numerical rating scale >7 within the first 24 h) and persistent pain at 3 months. RESULTS: Of the 104 patients included, 36 (34.6%) developed rebound pain. Preoperative nocturnal awakening pain (odds ratio [OR]=3.09, P=0.03), severe anxiety (OR=3.54, P=0.01), high catastrophising score (OR=4.14, P=0.01), and low salivary cortisol levels (<1147 pg ml-1) (OR=3.33, P=0.02) were associated with an increased risk of rebound pain. Persistent pain at 3 months (27%) was associated with the presence of postoperative rebound pain (P=0.04). CONCLUSIONS: Preoperative nocturnal pain, severe anxiety, high catastrophising, and low salivary cortisol levels are factors that might reduce the efficacy of dexamethasone in preventing rebound pain. These findings support the development of personalised preventive strategies. CLINICAL TRIAL REGISTRATION: NCT05763433.
引用
- Touil N, Pavlopoulou A, Barbier O, et al. Factors associated with a reduction in the preventive effect of intravenous dexamethasone on rebound pain after axillary brachial plexus block. Br J Anaesth. 2025. PMID: 40701886. doi:10.1016/j.bja.2025.05.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。